rethinkPeptides Search
Menu
Study breakdown

Ghrelin Beyond Neuroendocrinology: Immunity, Reproduction, Cancer, and Cardiovascular Effects

ReviewModerate evidence
The takeaway

Ghrelin's expanding biology now includes immune modulation, reproductive function, cancer cell effects, and cardiovascular protection — transforming it from a neuroendocrine curiosity to a multi-system regulator.

Key finding

Ghrelin's biological roles expanded to include immune modulation (anti-inflammatory), reproductive function, cancer cell growth regulation, and cardio

What the researchers found

Ghrelin's biological roles expanded to include immune modulation (anti-inflammatory), reproductive function, cancer cell growth regulation, and cardiovascular protection through GHS-R and non-GHS-R pathways.

Why it matters

Advances understanding in ghrp, hormone-optimization, neuropeptides research.

How the study worked

review study. Details in abstract.

What this study cannot tell us

See abstract for study-specific limitations.

How to read the evidence

moderate evidence from review study.

When this study was published

Published in 2004.

The bigger picture

Contributes to the growing body of evidence in peptide research.

Questions still open

  • Further research needed to confirm and extend findings.
  • Clinical translation potential to be evaluated.

Common questions

What was studied?
Ghrelin Beyond Neuroendocrinology: Immunity, Reproduction, Cancer, and Cardiovascular Effects
What was found?
Ghrelin's expanding biology now includes immune modulation, reproductive function, cancer cell effects, and cardiovascular protection — transforming it from a neuroendocrine curiosity to a multi-system regulator.

Read the original research

Ghrelin: more than a new frontier in neuroendocrinology.

Journal of endocrinological investigation, 27(6 Suppl), 101-4

Citation

Ghigo, E; Broglio, F; Me, E; Prodam, F; Ragazzoni, F. (2004). Ghrelin: more than a new frontier in neuroendocrinology.. Journal of endocrinological investigation, 27(6 Suppl), 101-4.